Agustina Rina, Lukito Widjaja, Firmansyah Agus, Suhardjo Hartati Ningsih, Murniati Dewi, Bindels Jacques
SEAMEO TROPMED Regional Center for Community Nutrition, University of Indonesia, Campus of UI Salemba, Jl. Salemba Raya no. 6, Jakarta 10430, Indonesia, PO BOX 3852, Jakarta, Indonesia.
Asia Pac J Clin Nutr. 2007;16(3):435-42.
A randomized double blind clinical trial was conducted to assess the efficacy of a special infant formula containing Lactobacillus rhamnosus LMG P-22799 (probiotic: 5 x 10(8) CFU/100mL), inulin (prebiotic: 0.15 g/100mL), dietary fiber (soy polysaccharides: 0.2 g/100mL) and increased amounts of zinc+iron (+0.4 and +0.6 mg/100mL, respectively) as active ingredients for the early dietary management of 58 Indonesian well-nourished male infants aged 3-12 months suffering from acute diarrhea with moderate dehydration. After adequate oral rehydration, the patients were randomly assigned to receive either a low lactose infant formula supplemented with added precooked rice (1.5 g/100mL) with the above active ingredients (study group) or a low lactose infant formula with added precooked rice without the above active ingredient supplement (control group). No antibiotic, anti-secretory drug or antiemetic was given at all. Both study and control groups showed similar outcomes for weight gain and stool weight. The duration of diarrhea was significantly shorter in the study group than in the control group (1.63 versus 2.45 days; p<0.05; for the study and control group respectively). No treatment failure or other side effects were observed during the course of the study. The present study supports the evidence for the efficacy of a special anti-diarrhea infant formula containing probiotic, prebiotic, fiber and iron+zinc after oral rehydration by shortening the duration of infantile diarrhea in developing countries. However, from the results of our study we cannot discern the individual contribution of the active ingredients and also not whether they may act independent from each other or in a synergistic way.
进行了一项随机双盲临床试验,以评估一种特殊婴儿配方奶粉的疗效。该配方奶粉含有鼠李糖乳杆菌LMG P - 22799(益生菌:5×10⁸CFU/100mL)、菊粉(益生元:0.15g/100mL)、膳食纤维(大豆多糖:0.2g/100mL)以及增加量的锌和铁(分别为+0.4和+0.6mg/100mL),作为58名3至12个月大、营养良好、患有中度脱水急性腹泻的印度尼西亚男婴早期饮食管理的活性成分。在充分口服补液后,将患者随机分配接受添加了上述活性成分的预煮大米(1.5g/100mL)的低乳糖婴儿配方奶粉(研究组),或添加了预煮大米但未添加上述活性成分的低乳糖婴儿配方奶粉(对照组)。整个过程未给予抗生素、抗分泌药物或止吐药。研究组和对照组在体重增加和粪便重量方面显示出相似的结果。研究组的腹泻持续时间明显短于对照组(分别为1.63天和2.45天;p<0.05)。在研究过程中未观察到治疗失败或其他副作用。本研究支持了一种含有益生菌、益生元、纤维和铁+锌的特殊抗腹泻婴儿配方奶粉在口服补液后通过缩短发展中国家婴儿腹泻持续时间而具有疗效的证据。然而,从我们的研究结果中,我们无法辨别活性成分的个体贡献,也无法确定它们是相互独立起作用还是协同作用。